Bailard, Inc. Bio Path Holdings Inc Transaction History

Bailard, Inc.

  • $3.8 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 25, 2022
SELL
$2.99 - $4.17 $100,227 - $139,782
-33,521 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$3.77 - $5.24 $126,374 - $175,650
33,521 New
33,521 $126,000

About BIO-PATH HOLDINGS INC

BPTH Quotes by TradingView
  • Ticker BPTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,160,160
  • Market Cap $6.37M
  • Description
  • Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...
More about BPTH
Track This Portfolio

Track Bailard, Inc. Portfolio

Follow Bailard, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email